Table 2 Prevalences for the use of illicit or prescription drugs for pharmacological neuroenhancement among students at the University of Mainz (n = 3984).
Use of any surveyed substance | Never used | Used | |||
|---|---|---|---|---|---|
Total responses | Within the last month | Within the last 12 months | More than 12 months ago | ||
Prescription and illicit drugs | |||||
Methylphenidate | 97.1% (n = 3868) | 2.9% (n = 115) | 0.7% (n = 26) | 0.7% (n = 28) | 1.6% (n = 61) |
Amphetamine preparation | 99.6% (n = 3969) | 0.4% (n = 14) | 0.1% (n = 4) | 0.1% (n = 3) | 0.8% (n = 7) |
Atomoxetine | 99.8% (n = 3976) | 0.2% (n = 7) | 0.1% (n = 5) | < 0.1% (n = 1) | < 0.1% (n = 1) |
Modafinil | 99.5% (n = 3965) | 0.5% (n = 18) | 0.2% (n = 9) | 0.1% (n = 4) | 0.1% (n = 5) |
Ecstasy (MDMA) | 98.3% (n = 3917) | 1.7% (n = 67) | 0.3% (n = 13) | 0.6% (n = 25) | 0.7% (n = 29) |
Ephedrine | 99.6% (n = 3967) | 0.4% (n = 15) | 0.1% (n = 2) | 0.2% (n = 6) | 0.2% (n = 7) |
Cocaine | 98.7% (n = 3931) | 1.3% (n = 53) | 0.2% (n = 8) | 0.4% (n = 17) | 0.7% (n = 28) |
Amphetamine | 98.2% (n = 3914) | 1.8% (n = 70) | 0.4% (n = 17) | 0.5% (n = 19) | 0.9% (n = 34) |
Crystal Meth | 99.9% (n = 3980) | 0.1% (n = 4) | < 0.1% (n = 1) | 0.1% (n = 2) | < 0.1% (n = 1) |
Cannabis | 89.3% (n = 3557) | 10.7% (n = 426) | 3.6% (n = 142) | 3.6% (n = 142) | 3.6% (n = 142) |
Other substances | 96.9% (n = 3860) | 3.1% (n = 124) | 1.4% (n = 55) | 0.9% (n = 36) | 0.8% (n = 33) |
